NACL Industries Fund Raise of ₹249.3 Cr

NACL Industries Annual General Meeting

NACL Industries is seeking shareholder approval via postal ballot for a material related party transaction involving a Letter of Comfort for its subsidiary.

Value

₹55.00 Cr

Execution

3 years

NACL Industries Annual General Meeting

NACL Industries Limited issued a Postal Ballot Notice seeking member approval for a Material Related Party Transaction with Coromandel International Limited.

NACL Industries Other Announcement

NACL Industries Limited filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.

NACL Industries Merger & Restructuring

NACL Industries Limited has executed a Share Purchase Agreement for the divestment of its equity stake in Nasense Labs Private Limited. This follows prior board approval for the sale.

NACL Industries Q1 FY27 Results: Net Profit ₹20.8 Cr, Up 60.0% YoY

NACL Industries Ltd reported net profit of ₹20.8 Cr (+60.0% YoY) for Q1 FY27.

Key figure

Net profit ₹20.8 Cr · +60.0% YoY

NACL Industries Annual General Meeting

NACL Industries Limited conducted its 39th Annual General Meeting on July 22, 2026. Shareholders adopted financial statements and approved the discussed agenda items.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.